Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
42 participants
INTERVENTIONAL
2011-02-28
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
the Research of Analgesia and Sedation Effect of Remifentanil on ICU Short Operation
NCT02635802
Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval
NCT03458143
Effect of Ketamine+Propofol vs Remifentanyl+Propofol on Laryngeal Mask Insertion Conditions
NCT02583217
The Effects of Remifentanil on Attenuating the Hemodynamic Responses After Electroconvulsive Therapy
NCT02271555
Remifentanil Requirement for Acceptable Intubating Condition
NCT02655380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ultiva,remifentanil,opioid,analgesic
Remifentanil:1.5ng/ml remifentanil infusion maintained at the end of the surgery
remifentanil
1-4 ng/mL i.v. infusion during the surgery, maintenance dosage till LMA removal is 1.5 ng/mL.
control
Control:Remifentanil stopped at the end of the surgery
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
remifentanil
1-4 ng/mL i.v. infusion during the surgery, maintenance dosage till LMA removal is 1.5 ng/mL.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18-60 years old
* presenting for ureterorenoscopy
Exclusion Criteria
* asthma and chronic obstructive lung disease
* recent respiratory tract infections
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Diskapi Teaching and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
derya özkan
MD consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jülide Ergil, MD
Role: STUDY_CHAIR
Ministry of Health Dıskapi Yildirim Beyazit Training and Research Hospital, Anesthesiology 1.
Alp Alptekin, MD
Role: STUDY_CHAIR
Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital, Anesthesiology 1
Nihan Aktürk, MD
Role: STUDY_CHAIR
Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital , Anesthesiology 1
Haluk Gümüs, MD
Role: STUDY_CHAIR
Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital, Anesthesiology 1
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ministry of Health Diskapi Yildirim Beyazit Research and Training Hospital departement of 1. Anesthesiology
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nho JS, Lee SY, Kang JM, Kim MC, Choi YK, Shin OY, Kim DS, Kwon MI. Effects of maintaining a remifentanil infusion on the recovery profiles during emergence from anaesthesia and tracheal extubation. Br J Anaesth. 2009 Dec;103(6):817-21. doi: 10.1093/bja/aep307. Epub 2009 Oct 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DiskapiTRH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.